- Record: found
- Abstract: not found
- Article: not found
Safety of Ombitasvir/paritaprevir/ritonavir plus dasabuvir for treating HCV GT1 infection in patients with severe renal impairment or end-stage renal disease: The RUBY-I-Study
P.J. Pockros, K.R. Reddy, P.S. Mantry, E. Cohen, M. Bennett, M.S. Sulkowski, D. Bernstein, T. Podsadecki, D. Cohen, N.S. Shulman
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.